Sun Pharma Drug is Approved for the Covid-19 Clinical Trials

Hello,
The Sun pharmaceutical industries has reported that it has received approval from the Drugs Controller General of India (DCGI) to conduct clinical trials involving treatment of covid-19 patients with the drug named as Nafamostat Mesilate. The same drug has been approved in Japan for the treatment of acute symptoms of pancreatitis and disseminated intravascular coagulation (DIC).

According to Sun pharmaceuticals Nafamostat has shown promising data against SARS-COV2 virus in in-vitro studies conducted by three independent groups of scientists in Europe, Japan and South Korea.

Researchers from University of Tokyo and Leibniz (Germany) Institute of Primate Research reportedly have demonstrated Nafamostat, dosed in very low concentrations, suppresses a protein (TMPRSS2) that the covid-19 virus uses to enter the human lung cells. Additionally, Scientist with Institu Pasteur in south Korea reportedly compared the antiviral efficacy of Nefamostat and 24 other drugs against SARS-Cov2 in in-vitro studies in human lung epithelial derived cells, finding Nafamostat as most potent drug.

JNU-CEEB is now GAT-B

Hello,

Previously called as JNU-Combined Entrance Examination for Biotechnology (CEEB) is now The "Graduate Aptitude Test - Biotechnology" (GAT-B).

This examination is now being conducted by the Regional Centre for Biotechnology on behalf of the Department of Biotechnology, Government of India.
 
This examination is to rank the eligibility of the candidate among all applicants. The candidates will be given a GAT-B rank based on which they may apply to the various DBT-supported PG programmes in participating institutions. 

The participating institutions will advertise and admit students as per their admission and selection process.

All students admitted under the DBT-supported programmes of any participating institution will be paid the stipend as under:

a) M.Sc. in Biotechnology & Allied Areas – Rs. 5000/- per month
b) M.Sc. in Agricultural Biotechnology – Rs. 7500/- per month
c) M.Tech./M.V.Sc. programmes – Rs. 12000/- per month

Online registration starts- 01st of June 2020
Online registration closes- 18th of June 2020
Date of examination of GAT-B -30th June 2020 

The examination will take place in 58 cities across India.

Students are advised to please check the eligibility criteria, syllabus and other details

Interested candidates can check the link below for complete information.

Graduate Aptitude Test - Biotechnology (GAT-B)

All The Best...!!!